I-BET762
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- BET Bromodomain inhibitor, Suppresses Myc transcription
- Produktmerkmale
- I-BET762 is a potent inhibitor of the BET family of bromodomains with no activity at bromodomains BAZ2B, SP140, ATAD2, CREBBO, and PCAF. IC50's for H4Ac peptide displacement: BRD2 = 32.5nM, BRD3 = 42.4nM, BRD4 = 36.1nM. It was able to suppress proinflammatory proteins by macrophage, block acute inflammation in mice, and suppressed the inflammatory function of T cells. Inhibition of BET bromodomains results in downregulation of Myc transcription, an important oncogene.
- Reinheit
- >98 %
- Chemical Name
- (4S)- 6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide
- Formel
- C22H22ClN5O2
- Löslichkeit
- Soluble in DMSO (up to at least 25 mg/ml) or in Ethanol (up to at least 25 mg/ml)
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Vorsichtsmaßnahmen
-
GHS – Classification
Not a hazardous substance or mixture - Lagerung
- -20 °C
-
- Hintergrund
- GSK525762,Epigenetics,Bromodomain,Immunology,Inflammation,Cancer,Posttranslational modification,Chromatin
- Molekulargewicht
- 423.90
- CAS-Nummer
- 1260907-17-2
-